NEULAND LAB LTD.

{
    "company_profile": "Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.",
    "sector": "Pharmaceuticals",
    "sector_market_cap_inr": {
        "value": 27796.28,
        "unit": "crore",
        "formatted": "27,796.28 Cr"
    },
    "sector_market_cap_usd": {
        "value": 3.09,
        "unit": "billion",
        "formatted": "$3.09B"
    }
}